Evaluates gastrointestinal tolerance and antagonistic potential of probiotic juice, suggesting its biopreservative role.
This study evaluated the gastrointestinal tolerance and antagonistic potential of probiotic-fermented tomato–watermelon juice formulated with Lactiplantibacillus plantarum LP01 and Bifidobacterium lactis BB12. A 75:25 (tomato: watermelon) formulation inoculated with 1.0% probiotics was selected based on physicochemical stability and viability (≥8 log 10 CFU/mL). Under simulated gastrointestinal conditions, probiotic counts remained above 6 log 10 CFU/mL, with intestinal counts reaching 9.71 log 10 CFU/mL, and only minor reductions under gastric and bile stress. Antagonistic assay demonstrates that during 72 h storage, fermented samples effectively inhibited Bacillus cereus, Bacillus subtilis, Staphylococcus aureus, Salmonella Enteritidis, Salmonella Typhimurium, and Enterococcus faecalis in fermented samples at both 4°C and 25°C, whereas nonfermented controls supported pathogens’ growth up to 8.56 log 10 CFU/mL at 25°C. Probiotic populations remained ≥8 log 10 CFU/mL during storage and reached approximately 8.4 log 10 CFU/mL at 25°C, while fermentation reduced pH to 3.0–3.4, contributing to antimicrobial activity. These findings confirm strong gastrointestinal tolerance, sustained probiotic viability, and effective biopreservative capacity of the fermented formulation.
No takes yet. Share an insight, caveat, or question.
Padmanabhan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: